Member Policies - Medical Policies - Alabama
Policies & Guidelines
- Advanced Imaging
- Autism Spectrum Mandate
- Behavioral Health
- Blue Advantage Policies
- Chronic Condition Management
- Genetic Testing
- Hemophilia Drugs
- Medical Policies
- Provider-Administered Drug Policies (Excluding Oncology)
- Provider-Administered Oncology Drug Policies
- Radiation Therapy
- Self-Administered Drug Policies
- Transgender Services
Effective January 1, 2021, Blue Cross and Blue Shield of Alabama will partner with AIM Specialty Health®, an independent company, to administer genetic testing solutions for our customers.
Use the navigation on the left to expand the menu to the draft and current policy pages.
Node: bclrgrpappp1001.corp.bcbsal.org:8080